New Jersey Doctor Indicted On Charges He Sold Oxycodone Prescriptions To Patients With No Legitimate Need For The Drug
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • New Jersey Doctor Indicted On Charges He Sold Oxycodone Prescriptions To Patients With No Legitimate Need For The Drug

New Jersey Doctor Indicted On Charges He Sold Oxycodone Prescriptions To Patients With No Legitimate Need For The Drug

March 02, 2017
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

TRENTON, N.J. - - Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, and New Jersey State Attorney General Christopher S. Porrino announced the indictment of a doctor from Passaic County for selling prescriptions of Oxycodone to patients, including those he knew to be addicts and drug dealers.

Dr. Byung Kang, 77, of Little Falls, N.J., who operated a family/general practice out of an office in Little Falls, was indicted yesterday by a state grand jury on charges of strict liability for drug-induced (1st degree), money (1st degree), (2nd degree), unlawful distribution of (2nd degree), unlawful  distribution of oxycodone within 1,000 feet of a (3rd degree), filing a fraudulent state tax (3rd degree), and failure to pay state income (3rd degree).  Kang’s wife, Soo Kang, 73, who acted as the receptionist for Kang’s medical practice, is charged along with him in the money laundering, conspiracy and tax-related counts of the indictment.

The charges are the result of an investigation by the New Jersey Division of Criminal Justice Gangs & Organized Crime Bureau, the DEA New Jersey Division Tactical Diversion Squad, and the New Jersey Division of Consumer Affairs Enforcement Bureau. 

From June 2010 through April 2016, Kang allegedly sold 90-count prescriptions for 30 milligram oxycodone pills to numerous patients for $150 or $200 when the patients had no medical need for the potent pain pills.  Kang’s own records allegedly revealed that he knew many of those patients were addicted to oxycodone or were reselling the pills.  Kang is charged with strict liability for drug-induced death in the death of Michael Justice, 26, of Clifton, who was found dead of an oxycodone overdose on Dec. 6, 2014 in a bedroom of his home, where empty bottles for oxycodone prescribed by Kang were recovered, including an empty bottle for a prescription filled just five days earlier.  Eighteen months before he died, Justice’s mother called Kang and threatened to call police if Kang did not stop prescribing oxycodone for her son, but Kang allegedly continued to write prescriptions until Justice’s death, without medical justification.

“Doctors are supposed to preserve health and life, but Dr. Kang allegedly turned his back on all medical and ethical standards, not to mention all standards of human decency,” said Attorney General Porrino.  “By indiscriminately peddling this dangerous painkiller - which has been the gateway to so much opiate addiction, misery and death - Dr. Kang allegedly caused the death of a vulnerable young man and put himself on a par with every street-corner drug dealer.”

Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division said, “Unfortunately, this is another example of a doctor who was allegedly more concerned with his financial health than the health of his patients.  He allegedly disregarded his patients’ addictions and kept prescribing oxycodone without justification, which resulted in the death of Michael Justice.”

The state seized $564,304 in U.S. currency during the execution of a search warrant and seized $869,777 from bank accounts of the Kangs.  The money laundering count of the indictment charges that those sums are the proceeds of Dr. Kang’s criminal activity in distributing oxycodone.  The state has filed a forfeiture action to seize those proceeds. 

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Cheryl Ortiz, Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español